Highly efficient adenovirus-mediated gene transfer into renal cells in culture  by Chang, Hangil et al.
Kidney International, Vol. 47 (1995), pp. 322—326
Highly efficient adenovirus-mediated gene transfer into renal cells
in culture
HANGIL CHANG, TETSUO KATOH, MASAKUNI NODA, YuMI KANEGAE, IZUMU SAITO, SHIGETAKA AsANo,
and KIYOSHI KUROKAWA
Fourth and First Departments of Internal Medicine, University of Tokyo School of Medicine, and Laboratoty of Molecular Genetics, Institute of Medical
Science, University of Tokyo, Tokyo, Japan
Nephrologists, studying the function of the kidney which is
structurally so complex, have advanced their research analyzing
more and more elementary substructures. They proceded from
the whole organ, through dissected tubules, to cultured renal cells.
Information acquired in this way is essential in constructing, from
physicochemical principles, our integrated view of the renal
function. In this direction of research one further promising step
would be to purposefully express the relevant molecules in
cultured cells and evaluate their properties. Recent successes
in cloning the molecules essential for renal function encourage us
in attempting these types of experiments. For this purpose,
cultured renal cells would be a suitable host by mimicking natural
environment for those molecules, and we require a means for
efficiently introducing foreign genes into these cells.
Adenovirus-based vector is a recently developed gene transfer
system which has several advantages over the conventional meth-
ods such as calcium phosphate precipitation, DEAE dextran,
electroporation, and lipofectin [1, 2]. Adenovirus vector: (1) is
highly efficient in transferring foreign genes into cells and, unlike
retrovirus vectors, can be applicable for non-replicating cells; (2)
is easily multiplied in proper host cells; (3) accepts large DNA
fragments (up to 7.5 kb); and (4) achieves steady, although
transient, expression for weeks [2]. Regarding the safety of
adenovirus-based vectors: (1) a replication-deficient adenovirus
vector has been developed which lacks El and E3 regions from its
genome, and can proliferate only in defined host cells such as 293
cells; (2) live vaccination of adenovirus has had been safely
applied in humans [1]; and (3) most adult humans have acquired
immunity against adenovirus.
This study was undertaken to determine whether adenovirus-
based vector can direct efficient gene transfer into renal cells in
culture. Recombinant adenovirus vector, carrying E. coli lacZ
gene as the reporter gene, was constructed by homologous
recombination and used for the experiments. Three types of renal
cells were examined: one mesangial (primary cultured rat glomer-
ular mesangial cells) and two tubular (LLCPKI and MDCK cells).
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Methods
Cell culture
Primary culture of rat glomerular mesangial cells was as
described previously [3]. LLCPK1 and MDCK cells were obtained
from the Japanese Cancer Research Resources Bank. They were
maintained with DMEM medium supplemented with 10% heat-
inactivated fetal calf serum (FCS), 100 U/mi penicillin, and 100
g/ml streptomycin. Trypsin-EDTA solution (0.5 g/liter trypsin
and 0.2 g/liter EDTA 4Na) was used to detach the cells for
subculture.
Adenovirus vector
The recombinant adenovirus Adex1EFLacZL, carrying lacZ
gene which codes for a E. coli 3-galactosidase, was constructed by
homologous recombination between the expression cosmid cas-
sette and the parental virus genome. The method was a modifi-
cation of Saito et al [4] and the detailed procedure will be
published elsewhere (Miyake et al, manuscript in preparation).
Briefly, the expression cosmid cassette was constructed by insert-
ing the expression unit, comprised of the elongation factor lcs
(EF1a) promoter, lacZ coding sequence, and polyA sequence,
into the Swa! site of pAdexiw. We used EFlcs promoter because
it is not only very potent but also effective in a wide range of cell
types [5]. pAdexiw is a 42 kb cosmid containing 31 kb adenovirus
type 5 genome lacking E1A, E1B, and E3 genes. The expression
cosmid cassette and adenovirus DNA-terminal protein complex
(DNA-TPC) was cotransfected into 293 cells by the calcium
phosphate precipitation method. DNA-TPC is the viral genome
with its terminal proteins covalently bound to its 5' ends. The 293
cell, derived from human embryonic kidney, is transformed by
incorporating adenovirus E1A and E1B genes into its genome; it
allows proliferation of E1A and E1B deleted replication-deficient
adenovirus vectors. DNA-TPC was purified from HeLa cells
infected with Ad5-dlX [4], which is an adenovirus type 5 lacking
E3 region, by the CsCl density centrifugation method. DNA-TPC
was digested with EcoT22I, which cleaved the genomic DNA at
seven sites, thus destroying the regions including E1A, E1B, and
E2, but preserving the 21 kb right hand side of the genomic DNA.
Incorporation of the expression cassette into the isolated recom-
binant virus was confirmed by comparing the DNA fragment
pattern of the obtained adenovirus DNA and the expression
cassette after digestion with appropriate restriction enzymes. The
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Fig. 1. Diagram of the recombinant
AdexIEFLacZL genome. From wild type
adenovirus type 5, genomic regions for E1A,
E1B, and E3 were deleted (indicated by filled
triangles labeled "E1A & ElB" and "AE3".)
Expression cassette, consisting of promoter
of elongation factor-la (EF1a), E. coli
EE1 A & AE1B E3 /3-galactosidase gene (lacZ), and polyA tail,was incorporated in place of E1A and E1B.
Arrow indicates the transcriptional direction of
Adex 1EFLacZL the expression cassette.
Fig. 3. Dose dependency of lacZ gene expression
on the relative number of AdexIEFLacZL
applied. A. LLCPK1 cells infected with various
concentrations of Adex1EFLacZL. Cells were
seeded in 16 mm diameter culture well and
infected with 18 .d of virus solutions. f3-
Galactosidase activity was detected 48 hours
later. Concentrations of the virus solutions were
(from the left column of wells to the right) 0,
0.8 X 106 (0.65 moi), 0.8 X io (6.5 moi), 0.8 X
108 (65 moi), and 0.8 >< io pfu/ml (650 moi),
respectively. B to F: Magnified view (100 X
magnification) of the cells. B: 0 pfu/ml. C: 0.8
x 106 pfu/ml. D: 0.8 X i0 pfu/ml. E: 0.8 X i08
pfu/ml. F: 0.8 )< io pfu/ml. Horizontal bar
indicates 200 jim.
Fig. 4. Time-course of lacZ gene expression.
Cells were seeded in 16 mm diameter culture
wells and infected with 18 ii! of virus solution
(0.8 x 10 pfu/ml). Cells were stained for /3-
galactosidase activity 12 hours (B), 24 hours
(C), 48 hours (D), and 8 days later (E). Staining
of the cells mock-infected with the vehicle is
shown in A. Horizontal bar indicates 200 jim.
Fig. 2. /3-Galactosidase activity in mesangial,
LLCPKJ, and MDCK cells infected with
AdexJEFLacZL. Cells were seeded in 16 mm
diameter culture well and infected with 18 jil of
either Adex1EFLacZL (0.8 x i0 pfu/ml) or
DMEM with 5% FCS. After incubation at 37°C
for 48 hours, /3-galactosidase was detected by
activity stain (blue pigmentation) using X-gal as
substrate, A and B. Mesangial cells. C and D.
LLCPK1 cells. E and F: MDCK cells. A, C and
E were mock-infected with DMEM with 5%
FCS. B, D and F were infected with
Adex1EFLacZL. Horizontal bar indicates
200 Jim.
recombinant virus was subsequently propagated with 293 cells and In vitro infection
viral solution was stored at —80°C. The titer of viral stocks,
determined by plaque assay on 293 cells, was 0.8 x iO pfu We used subconfluent cells, seeded in 16 mm diameter culture
(plaque forming unit)/ml. wells, for in vitro adenovirus vector infection. After washing twice
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Table 1. Cell numbers of MDCK cells before and after virus infection
After mock- After AdexlEFLacZ
Before infection infection° infection'
Experiment 1 2.7, 2.6 (X 104/well)
Experiment 2 10.0, 13.0
Experiment 3 3.3, 3.6
Numbers of MDCK cells in a 16 mm diameter culture well 2 days after
cells were mock-infected with 18 p.l of control solution (DMEM contain-
in, 5% FCS)
Numbers of MDCK cells in a 16 mm diameter culture well 2 days after
cells were infected with 18 pJ of 0.8 X iO pfu/ml Adex1EFLacZL
with DMEM without FCS, cells were incubated in a viral solution
(18 pd/well) at 37°C for one hour, shaken every 20 minutes, and
cultured in growth medium for 12 hours to eight days, depending
on the experiments, before histochemical stain. Various concen-
trations of viral solutions were prepared by diluting the stock
solution (0.8 X iO pfu/ml) with DMEM containing 5% FCS.
Detection of /3-galactosidase activity
Histochemical staining of /3-galactosidase was conducted ac-
cording to MacGregor et a! [6]. In brief, after washed twice with
PBS, cells were fixed with 0.25% glutaraldehyde in PBS for 10
minutes at 4°C. After washed four times with PBS, they were
incubated in staining solution for three hours at 37°C. The
staining solution was comprised of 1 mg/mI 5-bromo-4-chloro-3-
indolyl-/3-D-galactopyranoside (X-gal), 2 mrvt MgCl2, 5 mM KFe
(CN)6, and 5 mM K4Fe (CN)6 in 100 m sodium phosphate buffer
(pH 7.4). f3-Galactosidase activity was detected as the develop-
ment of blue pigmentation due to the enzymatic cleavage of X-gal.
All the experiments were repeated at least three times with
consistent reproducibility.
Results and discussion
Genomic structure of Adex1EFLacZL
The genomic structure of Adex1EFLacZL is schematically
illustrated in Figure 1. The insertion point of the expression
cassette, as well as its transcriptional direction, are indicated.
Adex1EFLacZL has the following characteristics: (1) originates
from adenovirus type 5; (2) lacks E1A, E1B, and E3 regions from
its genome; and (3) has expression unit (comprised of EF1a
promoter, lacZ gene, and polyA tail) in place of E1A and E1B.
The E1A region is involved in transcriptional transactivation of
viral genes. The E1B region contributes to the shut-off of host
protein synthesis. The E3 region is thought to be involved in
retarding immune response in vivo, and is not required for viral
replication in cultured cells (such as 293 cells). Lacking EIA and
E1B, Adex1EFLacZL is expected to direct production of 13-galac-
tosidase under the EF1 a promoter without unrestrained expres-
sion of viral proteins nor hindered synthesis of host proteins.
Highly efficient transfection by Adex1EFLacZL
In all three types of cells, unequivocal J3-galactosidase activity
was detected when transfected with Adex1EFLacZL (Fig. 2, right
column: B, mesangial cells; D, LLCPK1 cells; F, MDCK cells). No
such activity was seen in mock-infected cells (Fig. 2, left column:
A, mesangial cells; C, LLCPK1 cells; E, MDCK cells). These
results show that: (1) Adex1EFLacZL successfully transferred
lacZ gene, which was properly expressed to produce functional
26.0, 30.4 31.2, 26.0
44.0, 34.0 48.0, 41.0
30.2, 33.4 39.0, 44.4
f3-galactosidase molecule; and (2) EF1a promoter is potent in all
three cell types. Remarkably, almost every treated cell exhibited
/3-galactosidase activity. It demonstrates the superior efficiency of
adenovirus-based vector compared with the conventional trans-
fection methods such as calcium phosphate precipitation and
DEAE dextran, which are usually successful only in several
percent of cells. Multiplicity of infection (moi), which is defined as
the numerical ratio of the viruses to the cells at the time of
infection, was in the range of 543 to 758 in these experiments.
Assuming that several hundred moi assures infection of all the
treated cells, we can expect to reliably introduce foreign gene into
at least i0 cells in usual experiments, as io° pfu Adex1EFLacZL
was easily prepared from 293 cells.
Such high efficiency of adenovirus-based vector would be of
special advantage in experiments investigating the cell function at
the single cell level (for example, patch-clamp recording), as the
experimenter can be confident that most of the cells examined
express the gene of interest.
The result that both mesangial and tubular cells accepted
adenovirus-based vector leads us to expect that this system would
be useful in the wide range of nephrologic investigation, from
studying mesangial cell function to exploring the molecular mech-
anism(s) of tubular transport. This was not entirely unexpected as
adenovirus vector system has already been successfully applied to
various cultured cell types including cultured B-lymphocyte [7],
T-lymphocyte [8], myocyte [9], and hepatoma cell line [10].
Dose-dependency of Adex1EFLacZL transfection
The /3-galactosidase activity detected at 48 hours after infection
was dependent on the number of vectors applied (that is, moi). As
shown in Figure 3A, /3-galactosidase activity in LLCPK1 cells
increased as moi was raised, from left to right, to 0, 0.65, 6.5, 65,
and 650. Figure 3 B-F are the magnified view of these cells. In this
representative experiment, moi as low as 6.5 was sufficient to
infect nearly all cells treated. Furthermore, they show not only the
number of /3-galactosidase positive cells but also the level of
/3-galactosidase activity in each cell increased as the vector
concentration was increased. This suggests that multiple copies of
vectors are incorporated into these cells as the relative vector
quantities are increased. Similar results were also obtained for
mesangial and MDCK cells.
Time-course of Adex1EFLacZL transfection
Figure 4 shows the time-course of expression of /3-galactosidase
in MDCK cells infected with Adex1EFLacZL (A, mock-infection;
B, 12 hours after infection; C, 24 hours; D, 48 hours; E, 8 days).
/3-Galactosidase activity was already detectable as early as 12
hours after infection. The activity gradually increased until 48
hours, and persisted at least eight days (Fig. 4E) after infection.
This prompt and stable expression of the introduced gene would
be helpful for wide range of experiments.
Non-toxicity of Adex1EFLacZL
Cellular toxicity of Adex1EFLacZL was examined by micro-
scopic appearance and proliferative ability of the infected cells.
Viruses sufficient to infect 100% of the cells (400 moi) was applied
in these experiments. Microscopic appearance of the cells infected
with Adex1EFLacZL was examined by phase-contrast microscopy
and compared with untreated cells. In all three cell types,
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morphological appearance of the infected cells was indistinguish-
able from untreated cells (data not shown). Proliferative ability of
MDCK cells was examined by counting the cell number at 48
hours after infection of Adex1EFLacZL. Results of three indepen-
dent experiments are presented in Table 1. Increases in cell numbers
were quite similar between mock-infected and infected cells: mock-
infected cells, 10.6-, 3.4- and 9.2-fold; Adex1EFLacZL-infected cells,
10.8-, 3.9- and 12.1-fold, in corresponding experiments. Preservation
of microscopic appearance and proliferative ability shows that ade-
novirus vector does not greatly disturb the basic cellular functions.
These harmless characteristics of Adex1EFLacZL would be
explained by the following points. First, Adex1EFLacZL lack-
ing E1A region, which is essential for the expression of viral genes,
did not cause unrestricted production of viral proteins. Second,
Adex1EFLacZL lacks E1B region, which is involved in the
shut-off of synthesis of host proteins. Third, transfection proce-
dure with Adex1EFLacZL requires only one hour of incubation
with culture medium containing the vector, without altering the
cellular environment very much. It contrasts with the conventional
transfection methods, such as calcium phosphate precipitation,
which usually need drastic change of cellular environment for
hours.
Summary
In summary, we have shown that adenovirus vector efficiently
introduced foreign gene into cultured renal cells both of mesang-
ial and tubular origin. Genes transferred were properly expressed
to produce the molecules of expected function. It was possible to
introduce the gene into nearly 100% of the cells treated. Expres-
sion of the gene began as early as 12 hours after the infection,
increased until 48 hours and persisted at least up to eight days.
Finally, the vector was non-toxic to the cells, as judged from
simple toxicity tests.
Successful application of adenovirus vector enables for us to
study function of pertinent molecules in suitable host cells and
opens a new way for examining renal cellular physiology and
pathophysiology.
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